137 related articles for article (PubMed ID: 19189650)
1. Radioiodinated methylene blue--a promising agent for melanoma scintigraphy: labelling, stability and in vitro uptake by melanoma cells.
Sobal G; Rodrigues M; Sinzinger H
Anticancer Res; 2008; 28(6A):3691-6. PubMed ID: 19189650
[TBL] [Abstract][Full Text] [Related]
2. Fully-automated radiosynthesis and in vitro uptake investigation of [N-methyl-¹¹C]methylene blue.
Schweiger LF; Smith TA
Anticancer Res; 2013 Oct; 33(10):4267-70. PubMed ID: 24122991
[TBL] [Abstract][Full Text] [Related]
3. Rapid preparation of 123I-labelled methylene blue and toluidine blue: potential new agents for parathyroid scintigraphy.
Blower PJ; Carter NJ
Nucl Med Commun; 1990 Jun; 11(6):413-20. PubMed ID: 2385427
[TBL] [Abstract][Full Text] [Related]
4. Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animals.
Link EM; Costa DC; Lui D; Ell PJ; Blower PJ; Spittle MF
Acta Oncol; 1996; 35(3):331-41. PubMed ID: 8679265
[TBL] [Abstract][Full Text] [Related]
5. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
[TBL] [Abstract][Full Text] [Related]
7. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
8. Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.
Link EM; Brown I; Carpenter RN; Mitchell JS
Cancer Res; 1989 Aug; 49(15):4332-7. PubMed ID: 2743321
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-tetrofosmin: a new agent for melanoma imaging?
Meghdadi S; Karanikas G; Schlagbauer-Wadl H; Jansen B; Chehne F; Rodrigues M; Pehamberger H; Sinzinger H
Anticancer Res; 1998; 18(4A):2759-62. PubMed ID: 9703942
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of a novel radioiodinated phenylacetamide and its homolog as theranostic agents for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Eur J Pharm Sci; 2016 Jan; 81():201-9. PubMed ID: 26517961
[TBL] [Abstract][Full Text] [Related]
11. Phenothiazine photosensitizers. III. Activity of methylene blue derivatives against pigmented melanoma cell lines.
Rice L; Wainwright M; Phoemix DA
J Chemother; 2000 Feb; 12(1):94-104. PubMed ID: 10768521
[TBL] [Abstract][Full Text] [Related]
12. Early detection of melanoma metastases with radioiodinated methylene blue.
Link EM; Blower PJ; Costa DC; Lane DM; Lui D; Brown RS; Ell PJ; Spittle MF
Eur J Nucl Med; 1998 Sep; 25(9):1322-9. PubMed ID: 9724383
[TBL] [Abstract][Full Text] [Related]
13. No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Appl Radiat Isot; 2005 Mar; 62(3):435-40. PubMed ID: 15607920
[TBL] [Abstract][Full Text] [Related]
14. Targeting melanoma with 211At/131I-methylene blue: preclinical and clinical experience.
Link EM
Hybridoma; 1999 Feb; 18(1):77-82. PubMed ID: 10211792
[TBL] [Abstract][Full Text] [Related]
15. Iodination and radiolabeling of alpha-allocryptopine with iodine-125.
Wei Y; Wei X; Wang Y; Liu X; Chu T; Hu S; Wang X
Appl Radiat Isot; 2005 Jan; 62(1):55-62. PubMed ID: 15498685
[TBL] [Abstract][Full Text] [Related]
16. Radioiodinated methylene blue for melanoma targeting: chemical characterisation and tumour selectivity of labelled components.
Blower PJ; Clark K; Link EM
Nucl Med Biol; 1997 May; 24(4):305-10. PubMed ID: 9257328
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
18. Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.
Huang WS; Cherng SC; Jen TK; Yu MH; Yeh MY
J Nucl Med Technol; 2000 Sep; 28(3):182-5. PubMed ID: 11001503
[TBL] [Abstract][Full Text] [Related]
19. Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma.
Pham TQ; Berghofer P; Liu X; Greguric I; Dikic B; Ballantyne P; Mattner F; Nguyen V; Loc'h C; Katsifis A
J Nucl Med; 2007 Aug; 48(8):1348-56. PubMed ID: 17631542
[TBL] [Abstract][Full Text] [Related]
20. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
